- Approval Id
- 7a7ae240a2696bd1
- Drug Approval Philippines Name
- Rotasiil-Liquid
- Product Name
- Rotasiil-Liquid
- Registration Number
- BR-1434
- Brand Name
- Rotasiil-Liquid
- Generic Name
- Rotavirus Vaccine, (Live
Attenuated)
- Dosage Form
- Oral Suspension
- Dosage Strength
- Formulation:
Each dose (2 mL) contains:
Live, Attenuated Bovine - Human Rotavirus Reassortant
[G1, G2, G3, G4, and G9]*
*Grown on Vero cells
**FFU= Focus-forming Unit
***CCID= Cell culture infectious disease
≥105.6 FFU**/serotype (NLT 6.30 log10 CCID 50*** per dose)
- Manufacturer
- Serum Institute of India Private Limited
- Importer
- Faberco Life Sciences, Inc.
- Distributor
- Faberco Life Sciences, Inc.
- Company Detail Path
- /organization/serum-institute-of-india-private-limited
- Issuance Date
- 28 November 2022
- Expiry Date
- 28 November 2027
- Classification
- Prescription Drug (RX)
